Products

Ira-audit-tool

Investment Tax CreditIntelligence.

ira-audit-tool.vercel.app Finance / Tax

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
Tinashe Nedi
No social account linked
Launched
8mo ago
2026-03-22 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Unlock the Full IRA Tax Credit Stack

    Mar 22 · 8mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2020-01-28

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pro
Unknown
may not remove SolarTruth branding or embed the tool on a client-facing domain
Ultra
Unknown
Ultra includes white label rights and requires approval
Enterprise
Contact sales
all APIs, custom SLA, and dedicated onboarding

Trial: None · Enterprise custom tier · Observed 2026-11-08 · Source page

Pages & changes

Tracked since 2026-03-22

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Ira-audit-tool cost?
Pro: Unknown; Ultra: Unknown; Enterprise: Contact sales. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Ira-audit-tool get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Ira-audit-tool and what platforms does it support?
Ira-audit-tool is catalogued under Tax: Investment Tax CreditIntelligence.. Supported platforms: API.

Related products in this category

Finance / Tax

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.